Photoreceptor degeneration in ABCA4-associated retinopathy and its genetic correlates

Maximilian Pfau, Catherine A Cukras, Laryssa A Huryn, Wadih M Zein, Ehsan Ullah, Marisa P Boyle, Amy Turriff, Michelle A Chen, Aarti S Hinduja, Hermann Ea Siebel, Robert B Hufnagel, Brett G Jeffrey, Brian P Brooks, Maximilian Pfau, Catherine A Cukras, Laryssa A Huryn, Wadih M Zein, Ehsan Ullah, Marisa P Boyle, Amy Turriff, Michelle A Chen, Aarti S Hinduja, Hermann Ea Siebel, Robert B Hufnagel, Brett G Jeffrey, Brian P Brooks

Abstract

BACKGROUNDOutcome measures sensitive to disease progression are needed for ATP-binding cassette, sub-family A, member 4-associated (ABCA4-associated) retinopathy. We aimed to quantify ellipsoid zone (EZ) loss and photoreceptor degeneration beyond EZ-loss in ABCA4-associated retinopathy and investigate associations between photoreceptor degeneration, genotype, and age.METHODSWe analyzed 132 eyes from 66 patients (of 67 enrolled) with molecularly confirmed ABCA4-associated retinopathy from a prospective natural history study with a median [IQR] follow-up of 4.2 years [3.1, 5.1]. Longitudinal spectral-domain optical coherence tomography volume scans (37 B-scans, 30° × 15°) were segmented using a deep learning (DL) approach. For genotype-phenotype analysis, a model of ABCA4 variants was applied with the age of criterion EZ-loss (6.25 mm2) as the dependent variable.RESULTSPatients exhibited an average (square-root-transformed) EZ-loss progression rate of [95% CI] 0.09 mm/y [0.06, 0.11]. Outer nuclear layer (ONL) thinning extended beyond the area of EZ-loss. The average distance from the EZ-loss boundary to normalization of ONL thickness (to ±2 z score units) was 3.20° [2.53, 3.87]. Inner segment (IS) and outer segment (OS) thinning was less pronounced, with an average distance from the EZ-loss boundary to layer thickness normalization of 1.20° [0.91, 1.48] for the IS and 0.60° [0.49, 0.72] for the OS. An additive model of allele severity explained 52.7% of variability in the age of criterion EZ-loss.CONCLUSIONPatients with ABCA4-associated retinopathy exhibited significant alterations of photoreceptors outside of EZ-loss. DL-based analysis of photoreceptor laminae may help monitor disease progression and estimate the severity of ABCA4 variants.TRIAL REGISTRATIONClinicalTrials.gov identifier: NCT01736293.FUNDINGNational Eye Institute Intramural Research Program and German Research Foundation grant PF950/1-1.

Keywords: Genetic diseases; Ophthalmology; Retinopathy.

Figures

Figure 1. Feature extraction.
Figure 1. Feature extraction.
(A) Six retinal layers were segmented using a convolutional neural network. (B) Subsequently, en face projections were generated for each layer. (C) The area of ellipsoid zone (EZ) loss (shown in red) could be identified on the photoreceptor outer segment (OS) thickness map. (D and E) To account for age and retinal topography, the retinal thickness data for each A-scan (i.e., pixel in the en face map) were normalized in a pointwise manner using normal data as z score. (E) Retinal layer thicknesses in relation to the EZ boundary were extracted along evenly spaced contour lines (0.43° between the contour lines). RPE, retinal pigment epithelium.
Figure 2. Progression of EZ-loss .
Figure 2. Progression of EZ-loss.
(A) The first panel shows the square-root-transformed progression of EZ-loss over time (with a rolling median filter, span: ±1 year). The red dashed line shows the mixed model estimate for EZ-loss progression. (B) The second panel shows the log-likelihood (y axis) for mixed models of EZ-loss (dependent variable) as a function of time (independent variable). Models were fit with a range of Box-Cox transformations (λ 0 to 1) of the dependent variable EZ-loss. Based on the log-likelihood (45), a Box-Cox transformation parameter λ of 0.4 was optimal, which approximates square-root transformation (i.e., Box-Cox λ of 0.5). Supplemental Figure 9 shows the EZ-loss progression for exemplary eyes. These plots include data acquired prior to the baseline visit of the natural history study up to the last visit of each patient (N of patients = 66).
Figure 3. Retinal layer abnormalities outside the…
Figure 3. Retinal layer abnormalities outside the area of ellipsoid zone (EZ) loss.
The line plots show the normalized retinal layer thicknesses (y axis) outside the area of EZ-loss in eyes with STGD1 as a function of the distance to the EZ-loss boundary (x axis). The horizontal, red, dashed lines denote ±2 z score units (i.e., the normative range). The vertical, black, dashed lines indicate the distances 0.43°, 1.29°, 2.58°, 5.16°, and 7.73° (multiples of a Goldmann III stimulus diameter) to the EZ-loss boundary, which correspond to the average distance to normalization of thickness for the inner retina (INNER), outer nuclear layer (ONL), and photoreceptor inner segments (IS) and outer segments (OS). For these distances, changes over time in layer thicknesses are shown in Figure 4. Of note, INNER, ONL, IS, and OS are all severely thinned even outside the area of EZ-loss. The retinal pigment epithelium (RPE) shows thickening outside of EZ-loss. For the choroid (CHO), no marked changes in terms of thickness are evident. These plots are based on the data from the baseline of the natural history up to the last visit of each patient (N of patients = 66).
Figure 4. Rate of change in layer…
Figure 4. Rate of change in layer thickness per year.
The parallel line plots show the change in normalized layer thicknesses (y axis) over time (x axis) as a function of the distance to the EZ-loss boundary at baseline (panels). Each line denotes data from an individual eye. The red dashed lines are derived from mixed model estimates for the change over time. Of note, there is no evidence of “retina-wide” photoreceptor loss in this cohort. These plots are based on the data from baseline of the natural history up to the last visit of each patient (N of patients = 66).
Figure 5. Comparison of the allele severity…
Figure 5. Comparison of the allele severity estimates with prior publications.
(A) The first panel shows the comparison to overlapping data on 12 variants from Cideciyan et al. 2009 (17). The x axis shows the delay of disease initiation relative to a null mutation as estimated by Cideciyan et al. 2009. The y axis shows the estimates for the delay of disease initiation relative to a null mutation in the present study (age of criterion EZ-loss minus 6.88 years [estimate for age of criterion EZ-loss for a null mutation]). Interestingly, these prior data explained (R2) 43.5% of the variability in the delay of disease initiation observed in our data. (B) The second panel shows the comparison to overlapping data on 12 variants from Fakin et al. 2016 (4). The x axis shows the ordinal-scaled classification from Fakin et al. 2016. The y axis shows the estimates for the delay of disease initiation relative to a null mutation in the present study. The red horizontal lines indicate the median in the observed delay of disease initiation for each category.

References

    1. Lewis RA, et al. Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet. 1999;64(2):422–434. doi: 10.1086/302251.
    1. Allikmets R, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15(3):236–246. doi: 10.1038/ng0397-236.
    1. Lambertus S, et al. Early-onset stargardt disease: phenotypic and genotypic characteristics. Ophthalmology. 2015;122(2):335–344. doi: 10.1016/j.ophtha.2014.08.032.
    1. Fakin A, et al. The effect on retinal structure and function of 15 specific ABCA4 mutations: a detailed examination of 82 hemizygous patients. Invest Ophthalmol Vis Sci. 2016;57(14):5963–5973. doi: 10.1167/iovs.16-20446.
    1. Lambertus S, et al. Progression of late-onset stargardt disease. Investig Ophthalmol Vis Sci. 2016;57(13):5186–5191.
    1. Müller PL, et al. Choroidal flow signal in late-onset stargardt disease and age-related macular degeneration: an OCT-angiography study. Invest Ophthalmol Vis Sci. 2018;59(4):AMD122–AMD131. doi: 10.1167/iovs.18-23819.
    1. Strauss RW, et al. Progression of Stargardt disease as determined by fundus autofluorescence over a 12-month period: ProgStar report no. 11. JAMA Ophthalmol. 2019;137(10):1134–1145. doi: 10.1001/jamaophthalmol.2019.2885.
    1. Müller PL, et al. Comparison of green versus blue fundus autofluorescence in ABCA4-related retinopathy. Transl Vis Sci Technol. 2018;7(5):13. doi: 10.1167/tvst.7.5.13.
    1. Sunness JS, et al. Abnormal visual function outside the area of atrophy defined by short-wavelength fundus autofluorescence in Stargardt disease. Invest Ophthalmol Vis Sci. 2020;61(4):36. doi: 10.1167/iovs.61.4.36.
    1. Cideciyan AV, et al. Predicting progression of ABCA4-associated retinal degenerations based on longitudinal measurements of the leading disease front. Investig Ophthalmol Vis Sci. 2015;56(10):5946–5955.
    1. Cideciyan AV, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13(5):525–534. doi: 10.1093/hmg/ddh048.
    1. Burke TR, et al. Quantitative fundus autofluorescence in recessive Stargardt disease. Invest Ophthalmol Vis Sci. 2014;55(5):2841–2852. doi: 10.1167/iovs.13-13624.
    1. Müller PL, et al. Quantitative fundus autofluorescence in ABCA4-related retinopathy -functional relevance and genotype-phenotype correlation. Am J Ophthalmol. 2021;222:340–350. doi: 10.1016/j.ajo.2020.08.042.
    1. Tanna P, et al. Cross-sectional and longitudinal assessment of the ellipsoid zone in childhood-onset Stargardt disease. Transl Vis Sci Technol. 2019;8(2):1. doi: 10.1167/tvst.8.2.1.
    1. Sparrow JR, et al. Quantitative fundus autofluorescence in mice: correlation with HPLC quantitation of RPE lipofuscin and measurement of retina outer nuclear layer thickness. Invest Ophthalmol Vis Sci. 2013;54(4):2812–2820. doi: 10.1167/iovs.12-11490.
    1. Whitmore SS, et al. Analysis of retinal sublayer thicknesses and rates of change in ABCA4-associated Stargardt disease. Sci Rep. 2020;10(1):16576. doi: 10.1038/s41598-020-73645-5.
    1. Cideciyan AV, et al. ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet. 2009;18(5):931–941. doi: 10.1093/hmg/ddn421.
    1. Heath Jeffery RC, et al. Classifying ABCA4 mutation severity using age-dependent ultra-widefield fundus autofluorescence-derived total lesion size. Retina. 2021;41(12):2578–2588. doi: 10.1097/IAE.0000000000003227.
    1. Khan M, et al. Detailed phenotyping and therapeutic strategies for intronic ABCA4 variants in Stargardt disease. Mol Ther Nucleic Acids. 2020;21:412–427. doi: 10.1016/j.omtn.2020.06.007.
    1. Feuer WJ, et al. Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol. 2013;131(1):110–111. doi: 10.1001/jamaophthalmol.2013.572.
    1. Strauss RW, et al. Progression of Stargardt disease as determined by fundus autofluorescence in the retrospective progression of Stargardt disease study (ProgStar report no. 9) JAMA Ophthalmol. 2017;135(11):1232–1241. doi: 10.1001/jamaophthalmol.2017.4152.
    1. Pfau M, et al. Light sensitivity within areas of geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2019;60(12):3992–4001. doi: 10.1167/iovs.19-27178.
    1. Müller PL, et al. Inferred retinal sensitivity in recessive Stargardt disease using machine learning. Sci Rep. 2021;11(1):1466. doi: 10.1038/s41598-020-80766-4.
    1. Müller PL, et al. Prediction of function in ABCA4-related retinopathy using ensemble machine learning. J Clin Med. 2020;9(8):2428. doi: 10.3390/jcm9082428.
    1. Sallo FB, et al. “En face” OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci. 2012;53(10):6145–6152. doi: 10.1167/iovs.12-10580.
    1. Birch DG, et al. Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol. 2013;131(9):1143–1150. doi: 10.1001/jamaophthalmol.2013.4160.
    1. Cai CX, et al. Quantifying the rate of ellipsoid zone loss in Stargardt disease. Am J Ophthalmol. 2018;186:1–9. doi: 10.1016/j.ajo.2017.10.032.
    1. Shen LL, et al. Natural history of autosomal recessive stargardt disease in untreated eyes: a systematic review and meta-analysis of study- and individual-level data. Ophthalmology. 2019;126(9):1288–1296. doi: 10.1016/j.ophtha.2019.05.015.
    1. Müller PL, et al. Progression of ABCA4-related retinopathy—prognostic value of demographic, functional, genetic, and imaging parameters. Retina. 2020;40(12):2343–2356. doi: 10.1097/IAE.0000000000002747.
    1. Lambertus S, et al. Asymmetric inter-eye progression in Stargardt disease. Invest Ophthalmol Vis Sci. 2016;57(15):6824–6830. doi: 10.1167/iovs.16-20963.
    1. Genead MA, et al. The natural history of stargardt disease with specific sequence mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci. 2009;50(12):5867–5871. doi: 10.1167/iovs.09-3611.
    1. Sangermano R, et al. ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease. Genome Res. 2018;28(1):100–110. doi: 10.1101/gr.226621.117.
    1. Sangermano R, et al. Photoreceptor progenitor mRNA analysis reveals exon skipping resulting from the ABCA4 c.5461-10T→C mutation in Stargardt disease. Ophthalmology. 2016;123(6):1375–1385. doi: 10.1016/j.ophtha.2016.01.053.
    1. Zhang N, et al. Protein misfolding and the pathogenesis of ABCA4-associated retinal degenerations. Hum Mol Genet. 2015;24(11):3220–3237. doi: 10.1093/hmg/ddv073.
    1. Lee W, et al. Cis-acting modifiers in the ABCA4 locus contribute to the penetrance of the major disease-causing variant in Stargardt disease. Hum Mol Genet. 2021;30(14):1293–1304. doi: 10.1093/hmg/ddab122.
    1. Khan M, et al. Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics. Genet Med. 2020;22(7):1235–1246. doi: 10.1038/s41436-020-0787-4.
    1. Runhart EH, et al. Association of sex with frequent and mild ABCA4 alleles in Stargardt disease. JAMA Ophthalmol. 2020;138(10):1035–1042. doi: 10.1001/jamaophthalmol.2020.2990.
    1. Fujinami K, et al. A longitudinal study of Stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol. 2013;155(6):1075–1088. doi: 10.1016/j.ajo.2013.01.018.
    1. Machida S, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 2000;41(10):3200–3209.
    1. Velaga SB, et al. Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease. Graefes Arch Clin Exp Ophthalmol. 2019;257(3):549–556. doi: 10.1007/s00417-018-04229-3.
    1. Gill JS, et al. Cellular imaging of inherited retinal diseases using adaptive optics. Eye (Lond) 2019;33(11):1683–1698. doi: 10.1038/s41433-019-0474-3.
    1. Pfau M, et al. Progression of photoreceptor degeneration in geographic atrophy secondary to age-related macular degeneration. JAMA Ophthalmol. 2020;138(10):1026–1034. doi: 10.1001/jamaophthalmol.2020.2914.
    1. Sadigh S, et al. Drusen and photoreceptor abnormalities in African-Americans with intermediate non-neovascular age-related macular degeneration. Curr Eye Res. 2015;40(4):398–406. doi: 10.3109/02713683.2014.925934.
    1. Cideciyan AV, et al. ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Investig Ophthalmol Vis Sci. 2005;46(12):4739–4746.
    1. Almohaimeed A, Einbeck J. Response Transformations for Random Effect and Variance Component Models. Accessed December 8, 2021.
    1. Bates D, et al. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.

Source: PubMed

3
Subscribe